Research & Development
Cassiopea submits NDA to US FDA for clascoterone cream 1% acne treatment
21 August 2019 - Pharmaceutical company Cassiopea SpA (SIX:SKIN) said on Tuesday that it has filed a New Drug Application (NDA) with the US Food and Drug Administration (FDA) seeking marketing approva...
US FDA grants Moderna's mRNA-1893 fast track designation
21 August 2019 - The United States Food and Drug Administration (FDA) has granted fast track designation to United States-based Moderna for its investigational Zika vaccine, mRNA-1893, it was reported...
HedgePath Pharmaceuticals updates change in name and ticker symbol
20 August 2019 - Biopharmaceutical company HedgePath Pharmaceuticals Inc (OTCQB:HPPI) announced on Monday that it proposes to change its name to INHIBITOR Therapeutics as well as a change its the tick...
Richter unveils biosimilar teriparatide Terrosa across European osteoporosis market
20 August 2019 - Budapest pharmaceutical company Gedeon Richter Plc Monday disclosed the availability of its EC ( European Commission) approved biosimilar teriparatide Terrosa across Europe for the tr...
The US FDA approves Xenleta (lefamulin) to treat community-acquired bacterial pneumonia
20 August 2019 - Public health agency the US Food and Drug Administration announced on Monday that it has approved the new antibiotic Xenleta (lefamulin) for the treatment of adults with community-acq...
Boston Scientific wins US FDA approval of ImageReady MRI for Vercise Gevia Deep Brain Stimulation System for PD patients
20 August 2019 - Medical company Boston Scientific Corporation (NYSE:BSX) reported on Monday the receipt of approval from the US Food and Drug Administration (FDA) for its ImageReady MRI labeling for ...